Long-term results of Boston keratoprosthesis surgery in Polish patients

[1] Dohlman CH, Schneider HA, Doane, MG. Prosthokeratoplasty. Am. J. Ophthalmol. 1974; 77: 694–700. DohlmanCH SchneiderHA DoaneMG Prosthokeratoplasty Am. J. Ophthalmol 1974 77 694 700 10.1016/0002-9394(74)90534-04596032 Search in Google Scholar

[2] Kitazawa K, Wakimasu K, Kayukawa K, Yokota I, Inatomi T, Hieda O, Sotozono C, Kinoshita S. Moderately long-term safety and efficacy of repeat penetrating keratoplasty. Cornea. 2018; 37: 1255–1259. KitazawaK WakimasuK KayukawaK YokotaI InatomiT HiedaO SotozonoC KinoshitaS Moderately long-term safety and efficacy of repeat penetrating keratoplasty Cornea 2018 37 1255 1259 10.1097/ICO.000000000000169430052560 Search in Google Scholar

[3] Srujana D, Kaur M, Urkude J, Rathi A, Sharma N, Titiyal JS. Long-term functional and anatomic outcomes of repeat graft after optically failed therapeutic keratoplasty. Am. J. Ophthalmol. 2018; 189: 166–175. SrujanaD KaurM UrkudeJ RathiA SharmaN TitiyalJS Long-term functional and anatomic outcomes of repeat graft after optically failed therapeutic keratoplasty Am. J. Ophthalmol 2018 189 166 175 10.1016/j.ajo.2018.03.01129550189 Search in Google Scholar

[4] Yildiz EH, Hoskins E, Fram N, Rapuano CJ, Hammersmith KM, Laibson PR, Cohen EJ. Third or greater penetrating keratoplasties: Indications, survival, and visual outcomes. Cornea. 2010; 29: 254–259. YildizEH HoskinsE FramN RapuanoCJ HammersmithKM LaibsonPR CohenEJ Third or greater penetrating keratoplasties: Indications, survival, and visual outcomes Cornea 2010 29 254 259 10.1097/ICO.0b013e3181b31b6f20118784 Search in Google Scholar

[5] Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, Kharashi SA, Jindan MA, Tandon R, Mascarenhas J, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012; 119: 1530–1538. AldaveAJ SangwanVS BasuS BasakSK HovakimyanA GevorgyanO KharashiSA JindanMA TandonR MascarenhasJ International results with the Boston type I keratoprosthesis Ophthalmology 2012 119 1530 1538 10.1016/j.ophtha.2012.02.01522512986 Search in Google Scholar

[6] Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011; 118: 1543–1550. GreinerMA LiJY MannisMJ Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis Ophthalmology 2011 118 1543 1550 10.1016/j.ophtha.2010.12.03221397948 Search in Google Scholar

[7] Priddy J, Bardan AS, Tawfik HS, Liu C. Systematic review and meta-analysis of the medium- and long-term outcomes of the Boston type 1 keratoprosthesis. Cornea. 2019; 38: 1465–1473. PriddyJ BardanAS TawfikHS LiuC Systematic review and meta-analysis of the medium- and long-term outcomes of the Boston type 1 keratoprosthesis Cornea 2019 38 1465 1473 10.1097/ICO.000000000000209831403526 Search in Google Scholar

[8] Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea. 2011; 30: 1187–1194. SejpalK YuF AldaveAJ The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency Cornea 2011 30 1187 1194 10.1097/ICO.0b013e318211446721885964 Search in Google Scholar

[9] Zerbe BL, Belin MW, Ciolino JB. Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006; 113: 1779.e1–7. ZerbeBL BelinMW CiolinoJB Boston Type 1 Keratoprosthesis Study Group Results from the multicenter Boston Type 1 Keratoprosthesis Study Ophthalmology 2006 113 1779.e1 7 10.1016/j.ophtha.2006.05.01516872678 Search in Google Scholar

[10] Bostan C, Nayman T, Szigiato AA, Morfeq H, Harissi-Dagher M. Endophthalmitis in eyes with the Boston type I keratoprosthesis: Incidence, recurrence, risk factors, and outcomes. Cornea. 2021; 40: 1258–1266. BostanC NaymanT SzigiatoAA MorfeqH Harissi-DagherM Endophthalmitis in eyes with the Boston type I keratoprosthesis: Incidence, recurrence, risk factors, and outcomes Cornea 2021 40 1258 1266 10.1097/ICO.000000000000264133394754 Search in Google Scholar

[11] Nascimento E, Silva R, Taniguchi EV, Cruzat A, Paschalis EI, Pasquale LR, Colby KA, Dohlman CH, Chodosh J, Shen LQ. Angle anatomy and glaucoma in patients with Boston keratoprosthesis. Cornea. 2020; 39: 713–719. NascimentoE SilvaR TaniguchiEV CruzatA PaschalisEI PasqualeLR ColbyKA DohlmanCH ChodoshJ ShenLQ Angle anatomy and glaucoma in patients with Boston keratoprosthesis Cornea 2020 39 713 719 10.1097/ICO.000000000000221631764284 Search in Google Scholar

[12] Sayegh RR, Pineda R 2nd. Practical applications of anterior segment optical coherence tomography imaging following corneal surgery. Semin. Ophthalmol. 2012; 27: 125–132. SayeghRR PinedaR2nd Practical applications of anterior segment optical coherence tomography imaging following corneal surgery Semin. Ophthalmol 2012 27 125 132 10.3109/08820538.2012.70727423163266 Search in Google Scholar

[13] Samy El Gendy NM, Li Y, Zhang X, Huang D. Repeatability of pachymetric mapping using fourier domain optical coherence tomography in corneas with opacities. Cornea. 2012; 31: 418–423. Samy El GendyNM LiY ZhangX HuangD Repeatability of pachymetric mapping using fourier domain optical coherence tomography in corneas with opacities Cornea 2012 31 418 423 10.1097/ICO.0b013e31823f098c329982922236789 Search in Google Scholar

[14] Szalai E, Németh G, Hassan Z, Módis L Jr. Noncontact evaluation of corneal grafts: Swept-source Fourier domain OCT versus high-resolution Scheimpflug imaging. Cornea. 2017; 36: 434–439. SzalaiE NémethG HassanZ MódisLJr Noncontact evaluation of corneal grafts: Swept-source Fourier domain OCT versus high-resolution Scheimpflug imaging Cornea 2017 36 434 439 10.1097/ICO.000000000000113328079690 Search in Google Scholar

[15] Wylegała E, Teper S, Nowińska AK, Milka M, Dobrowolski D. Anterior segment imaging: Fourier-domain optical coherence tomography versus time-domain optical coherence tomography. J. Cataract Refract. Surg. 2009; 35: 1410–1414. WylegałaE TeperS NowińskaAK MilkaM DobrowolskiD Anterior segment imaging: Fourier-domain optical coherence tomography versus time-domain optical coherence tomography J. Cataract Refract. Surg 2009 35 1410 1414 10.1016/j.jcrs.2009.03.03419631129 Search in Google Scholar

[16] Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, et al. TFOS DEWS II diagnostic methodology report. Ocul. Surf. 2017; 15: 539–574. WolffsohnJS AritaR ChalmersR DjalilianA DogruM DumbletonK GuptaPK KarpeckiP LazregS PultH TFOS DEWS II diagnostic methodology report Ocul. Surf 2017 15 539 574 10.1016/j.jtos.2017.05.00128736342 Search in Google Scholar

[17] Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003; 22: 640–650. BronAJ EvansVE SmithJA Grading of corneal and conjunctival staining in the context of other dry eye tests Cornea 2003 22 640 650 10.1097/00003226-200310000-0000814508260 Search in Google Scholar

[18] Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O’Brien T, Rolando M, Tsubota K, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol. Vis. Sci. 2011; 52: 2050–2064. GeerlingG TauberJ BaudouinC GotoE MatsumotoY O’BrienT RolandoM TsubotaK NicholsKK The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction Invest Ophthalmol. Vis. Sci 2011 52 2050 2064 10.1167/iovs.10-6997g307216321450919 Search in Google Scholar

[19] Ahmad S, Mathews PM, Srikumaran D, Aldave AJ, Lenis T, Aquavella JV, Hannush SB, Belin M, Akpek EK. Outcomes of repeat Boston type 1 keratoprosthesis implantation. Am. J. Ophthalmol. 2016; 161: 181–187.e1. AhmadS MathewsPM SrikumaranD AldaveAJ LenisT AquavellaJV HannushSB BelinM AkpekEK Outcomes of repeat Boston type 1 keratoprosthesis implantation Am. J. Ophthalmol 2016 161 181 187.e1 10.1016/j.ajo.2015.10.01226482467 Search in Google Scholar

[20] Chew HF, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, Jin YP, Cohen EJ. Boston keratoprosthesis outcomes and complications. Cornea. 2009; 28: 989–996. ChewHF AyresBD HammersmithKM RapuanoCJ LaibsonPR MyersJS JinYP CohenEJ Boston keratoprosthesis outcomes and complications Cornea 2009 28 989 996 10.1097/ICO.0b013e3181a186dc19724214 Search in Google Scholar

[21] Ciolino JB, Belin MW, Todani A, Al-Arfaj K, Rudnisky CJ. Boston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: Multicenter study results. Ophthalmology. 2013; 120: 1195–1200. CiolinoJB BelinMW TodaniA Al-ArfajK RudniskyCJ Boston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: Multicenter study results Ophthalmology 2013 120 1195 1200 10.1016/j.ophtha.2012.11.025367418823499061 Search in Google Scholar

[22] Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, Dong PN, Geerling G, Hida RY, Liu Y, et al. TFOS DEWS II management and therapy report. Ocul. Surf. 2017; 15: 575–628. JonesL DownieLE KorbD Benitez-Del-CastilloJM DanaR DengSX DongPN GeerlingG HidaRY LiuY TFOS DEWS II management and therapy report Ocul. Surf 2017 15 575 628 10.1016/j.jtos.2017.05.00628736343 Search in Google Scholar

[23] Kanu LN, Niparugs M, Nonpassopon M, Karas FI, de la Cruz JM, Cortina MS. Predictive factors of Boston type I keratoprosthesis outcomes: A long-term analysis. Ocul. Surf. 2020; 18: 613–619. KanuLN NiparugsM NonpassoponM KarasFI de la CruzJM CortinaMS Predictive factors of Boston type I keratoprosthesis outcomes: A long-term analysis Ocul. Surf 2020 18 613 619 10.1016/j.jtos.2020.07.01232702418 Search in Google Scholar

[24] Palioura S, Kim B, Dohlman CH, Chodosh J. The Boston keratoprosthesis type I in mucous membrane pemphigoid. Cornea. 2013; 32: 956–961. PaliouraS KimB DohlmanCH ChodoshJ The Boston keratoprosthesis type I in mucous membrane pemphigoid Cornea 2013 32 956 961 10.1097/ICO.0b013e318286fd7323538625 Search in Google Scholar

[25] Srikumaran D, Munoz B, Aldave AJ, Aquavella JV, Hannush SB, Schultze R, Belin M, Akpek EK. Long-term outcomes of Boston type 1 keratoprosthesis implantation: A retrospective multicenter cohort. Ophthalmology. 2014; 121: 2159–2164. SrikumaranD MunozB AldaveAJ AquavellaJV HannushSB SchultzeR BelinM AkpekEK Long-term outcomes of Boston type 1 keratoprosthesis implantation: A retrospective multicenter cohort Ophthalmology 2014 121 2159 2164 10.1016/j.ophtha.2014.05.03025017414 Search in Google Scholar

[26] Magalhães FP, Hirai FE, de Sousa LB, de Oliveira LA. Boston type 1 keratoprosthesis outcomes in ocular burns. Acta Ophthalmol. 2013; 91: e432–e436. MagalhãesFP HiraiFE de SousaLB de OliveiraLA Boston type 1 keratoprosthesis outcomes in ocular burns Acta Ophthalmol 2013 91 e432 e436 10.1111/aos.1208323406295 Search in Google Scholar

[27] Banitt M. Evaluation and management of glaucoma after keratoprosthesis. Curr. Opin. Ophthalmol. 2011; 22: 133–136. BanittM Evaluation and management of glaucoma after keratoprosthesis Curr. Opin. Ophthalmol 2011 22 133 136 10.1097/ICU.0b013e328343723d21191292 Search in Google Scholar

[28] Kang JJ, Allemann N, Cruz Jde L, Cortina MS. Serial analysis of anterior chamber depth and angle status using anterior segment optical coherence tomography after Boston keratoprosthesis. Cornea. 2013; 32: 1369–1374. KangJJ AllemannN CruzJde L CortinaMS Serial analysis of anterior chamber depth and angle status using anterior segment optical coherence tomography after Boston keratoprosthesis Cornea 2013 32 1369 1374 10.1097/ICO.0b013e3182a0cff523974896 Search in Google Scholar

[29] Rudnisky CJ, Belin MW, Todani A, Al-Arfaj K, Ament JD, Zerbe BJ, Ciolino JB, Boston Type 1 Keratoprosthesis Study Group. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: Multicenter study results. Ophthalmology. 2012; 119: 951–955. RudniskyCJ BelinMW TodaniA Al-ArfajK AmentJD ZerbeBJ CiolinoJB Boston Type 1 Keratoprosthesis Study Group Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: Multicenter study results Ophthalmology 2012 119 951 955 10.1016/j.ophtha.2011.11.030334321222361316 Search in Google Scholar

[30] Malhotra C, Dhingra D, Jain AK. Keratoprosthesis optic and carrier corneal graft “noncontact” as a cause of sterile stromal necrosis in a case of Auro KPro implantation. Indian J. Ophthalmol. 2019; 67: 685–686. MalhotraC DhingraD JainAK Keratoprosthesis optic and carrier corneal graft “noncontact” as a cause of sterile stromal necrosis in a case of Auro KPro implantation Indian J. Ophthalmol 2019 67 685 686 10.4103/ijo.IJO_1713_18649891031007242 Search in Google Scholar

[31] Poddar R, Cortés DE, Werner JS, Mannis MJ, Zawadzki RJ. Three-dimensional anterior segment imaging in patients with type 1 Boston keratoprosthesis with switchable full depth range swept source optical coherence tomography. J. Biomed. Opt. 2013; 18: 86002. PoddarR CortésDE WernerJS MannisMJ ZawadzkiRJ Three-dimensional anterior segment imaging in patients with type 1 Boston keratoprosthesis with switchable full depth range swept source optical coherence tomography J. Biomed. Opt 2013 18 86002 10.1117/1.JBO.18.8.086002373122723912759 Search in Google Scholar

[32] Shapiro BL, Cortés DE, Chin EK, Li JY, Werner JS, Redenbo E, Mannis MJ. High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis. Cornea. 2013; 32: 951–955. ShapiroBL CortésDE ChinEK LiJY WernerJS RedenboE MannisMJ High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis Cornea 2013 32 951 955 10.1097/ICO.0b013e318285c8f4374109123591146 Search in Google Scholar

[33] Zarei-Ghanavati S, Betancurt C, Mas AM, Wang J, Perez VL. Ultra high resolution optical coherence tomography in Boston type I keratoprosthesis. J. Ophthalmic Vis. Res. 2015; 10: 26–32. Zarei-GhanavatiS BetancurtC MasAM WangJ PerezVL Ultra high resolution optical coherence tomography in Boston type I keratoprosthesis J. Ophthalmic Vis. Res 2015 10 26 32 10.4103/2008-322X.156092442471426005549 Search in Google Scholar

[34] Iyer G, Srinivasan B, Agarwal S, Talele D, Rishi E, Rishi P, Krishnamurthy S, Vijaya L, Subramanian N, Somasundaram S. Keratoprosthesis: Current global scenario and a broad Indian perspective. Indian J. Ophthalmol. 2018; 66: 620–629. IyerG SrinivasanB AgarwalS TaleleD RishiE RishiP KrishnamurthyS VijayaL SubramanianN SomasundaramS Keratoprosthesis: Current global scenario and a broad Indian perspective Indian J. Ophthalmol 2018 66 620 629 10.4103/ijo.IJO_22_18593915029676302 Search in Google Scholar

[35] Lee R, Khoueir Z, Tsikata E, Chodosh J, Dohlman CH, Chen TC. Long-term visual outcomes and complications of Boston keratoprosthesis type II implantation. Ophthalmology. 2017; 124: 27–35. LeeR KhoueirZ TsikataE ChodoshJ DohlmanCH ChenTC Long-term visual outcomes and complications of Boston keratoprosthesis type II implantation Ophthalmology 2017 124 27 35 10.1016/j.ophtha.2016.07.01127538795 Search in Google Scholar

[36] Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, et al. TFOS DEWS II Epidemiology Report. Ocul. Surf. 2017; 15: 334–365. StapletonF AlvesM BunyaVY JalbertI LekhanontK MaletF NaKS SchaumbergD UchinoM VehofJ TFOS DEWS II Epidemiology Report Ocul. Surf 2017 15 334 365 10.1016/j.jtos.2017.05.00328736337 Search in Google Scholar